Accelerate Vaccine Development 

Explore how Dextramer® reagents can help you monitor antigen-specific immune cells and provide valuable insights into epitope discovery in vaccine development.

Get the full picture of the cellular immune response

Cutting-Edge Reagents for Detection of Antigen-Specific Immune Cells

Regardless of the vaccine type, vaccine development usually follows a rigid process.

Dextramer® technology can help you uncover antigen-specific immune cell responses and provide new insights into vaccine therapeutic efficacy and toxicity.

EXPLORE OUR VACCINE DEVELOPMENT SOLUTIONS

Get the full picture of the cellular immune response

Expand the limits of your research

Ensure consistent, reproducible, and comparable results

Secure flexibility in your experiments

Immudex is Your Trusted Partner in All the Phases of Vaccine Development

Exploratory

Perform massive multiplexing of antigen specificities in epitope discovery or neoantigen screenings by NGS using our dCODE Dextramer® and dCODE Klickmer® technology.

Pre-Clinical

Detect, monitor, and document the presence or responses of antigen‑specific immune cells in preclinical efficacy studies using MHC I or II Dextramer® and Klickmer® by flow cytometry.

Clinical

Detect and monitor antigen‑specific T-cell
responses in clinical trials using our Clinical‑Grade MHC Dextramer® (GMP) reagents that meet numerous requirements in accordance with quality system requirements for medical devices defined by ISO 13485 and 21 CFR 820.

Transform Your Vaccine Development

Every day, immunologists make new discoveries that deepen our understanding of how the immune system responds to disease for advanced vaccine development. Learn how Dextramer® technology can help transform your approach to develop vaccines against current and future disease. Get inspired by a selection of our educational material focused on vaccine development.

Why understanding antigen-specific immune cells is key to the development of next-generation cancer vaccines.

Capturing Primary and Secondary Anti-Yellow Fever Vaccine Response to Investigate the Dynamics of Antigen-Specific T Cells

Monitoring T cell dynamics in a Phase I trial of RNA vaccine for melanoma

Epitope discovery using the Klickmer® technology

 

Published Viral T-Cell Epitopes

To help you investigate virus-specific T cells, we’ve created curated lists of published viral T-cell epitopes.

Published Viral Human, Primate, and Mouse T-Cell Epitopes

Download the list of epitopes in viral infections

Published Human COVID-19 T-Cell Epitopes

Download the list of epitopes in COVID-19 infected or vaccinated individuals

Published Mouse COVID-19 T-Cell Epitopes

Download the list of epitopes in COVID-19 infected genetically modified mice

Want to Hear More About Our Vaccine Development Solutions? 

Fill in the form and one of our dedicated specialists will get in touch with you shortly